Acute promyelocytic leukemia (APL) is currently considered to be a highly curable disease. However, early death (ED) remains a major cause of treatment failure in APL. The purpose of this study was to retrospectively review the morphological, immunophenotypic and molecular characteristics of 26 patients with APL resulting in ED. It was observed that elevated white blood cell (WBC) counts, lower fibrinogen concentrations, morphological variant M3v, CD34 and the short form (S- or bcr3 form) of the transcript were significantly associated with ED, mainly due to cerebral hemorrhage. Admission on weekends or holidays without immediate diagnosis or prompt administration of treatment for APL resulted in intracranial bleeding and was the major cause of ED. Therefore, it is recommended that APL and coagulopathy management treatments are promptly initiated only upon morphological and clinical suspicion of APL on admission, in order to reduce the risk of severe bleeding and lower the rate of ED.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915273PMC
http://dx.doi.org/10.3892/mco.2013.155DOI Listing

Publication Analysis

Top Keywords

acute promyelocytic
8
promyelocytic leukemia
8
early death
8
apl
6
clinical characteristics
4
characteristics acute
4
leukemia manifesting
4
manifesting early
4
death acute
4
leukemia apl
4

Similar Publications

The biological and thermal properties of a class of synthetic dihydroimidazotriazinones were disclosed in this article for the first time. Molecules --as potential innovative antimetabolites mimicking bicyclic aza-analogues of isocytosine-were evaluated for their in vitro anticancer activity. Moreover, in vivo, in vitro, and ex vivo toxicity profiles of all the compounds were established in zebrafish, non-tumour cell, and erythrocyte models, respectively.

View Article and Find Full Text PDF

An obstacle for many microfluidic developments is the fabrication of its structures, which is often complex, time-consuming, and expensive. Additive manufacturing can help to reduce these barriers. This study investigated whether the results of a microfluidic assay for the detection of the promyelocytic leukemia (PML)-retinoic acid receptor α (RARα) fusion protein (PML::RARA), and thus for the differential diagnosis of acute promyelocytic leukemia (APL), could be transferred from borosilicate glass microfluidic structures to additively manufactured fluidics.

View Article and Find Full Text PDF

Background: Acute promyelocytic leukemia (APL) is characterized by abnormal promyelocytes and t(15;17)(q24;q21) . Rarely, patients may have cryptic or variant rearrangements. All-trans retinoic acid (ATRA)/arsenic trioxide (ATO) is largely curative provided that the diagnosis is established early.

View Article and Find Full Text PDF

Unlabelled: Acute myeloid leukemia (AML) is the most frequent type of leukemia in adults and has a high mortality burden. Patients over 60 years of age infrequently receive high-intensity chemotherapy.

Aim: To describe the clinical characteristics and evaluate the survival in patients with AML, focusing on patients over 60 years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!